Clarithromycin tablets to be launched in India soon
Ranbaxy Laboratories Limited has recently launched its approved generic formulation of clarithromycin// immediate release tablets in the US, according to a press release. Ranbaxy has been given the green signal to manufacture and market Clarithromycin tablets—250 mg and 500 mg under the Ranbaxy label. Clarithromycin tablets are indicated for the treatment of mild to moderate infections ca...Cadila gets US FDA approval for Promethazine tablets
Cadila Healthcare Ltd has received US Food Drug Administration (US FDA) approval to market Promethazine tablets 12.5 mg, 25 mg and 50 mg in the US.// Promethazine is an anti-emetic drug, used to treat allergic symptoms and reactions, to cause sedation, to assist in controlling postoperative pain and to control motion sickness. The company plans to launch the drug in US this ye...Manic Ecstasy: Man gets Into a Frenzy after a Record Consumption of 40,000 ecstasy tablets
Mr. A, is certainly not ecstatic, though he has created a record of sorts. Doctors in England are at their wits end, with details of a man, now open for public consumption, disclosing the highest record ever of consuming 40,000 //ecstasy pills in his life. Mr. A had absolutely no competition, as the second position for the’ecstacy’ record went to a certain person who was said to have cons...Three Arrested For Illegal Export Of Ephedrine Tablets
The Directorate of Revenue Intelligence arrested three persons, including the Managing Director of a pharmaceutical company based at Vijayawada//, for alleged illegal export of Ephedrine tablets, a controlled substance notified under the Narcotic Drugs and Psychotropic Substances (NDPS) Act, 1985. According to Directorate of Revenue Intelligence here today, the arrested persons have b...Ranbaxy Gets USFDA Approval For Doxycycline Tablets
Ranbaxy Laboratories Ltd has received approval from USFDA for manufacturing and marketing Doxycycline Tablets in the US market.// The company informed the Bombay Stock Exchange that it got the approval for marketing the antibiotic in strengths of 50mg, 75mg and 100mg. Doxycycline is indicated for a variety of infections caused by susceptible strains or micro-organisms inclu...Cadila Gets Tentative USFDA Nod For Pravastatin Sodium Tablets
Cadila Healthcare Ltd has received tentative approval from the USFDA to market Pravastatin Sodium Tablets in the US market. // The tentative approval was given for strengths of 10 mg, 20 mg, 40 mg and 80 mg, the company informed the Bombay Stock Exchange. The company would market the drug through its US subsidiary Zydus Pharmaceuticals (USA) Inc, following patent expiry, it...Lupin Gets USFDA Approval For Quinapril Tablets
Pharmaceutical company Lupin Ltd today said it has recieved the final approval from USFDA to market its Abbreviated New Drug Application (ANDA) of hypertension medicine Quinapril in US. // The company informed the Bombay Stock Exchange that the approval is for the multiple dosages of strengths 5 mg, 10 mg, 20 mg and 40 mg. Quinapril is a AB-rated generic equivalent of Pfiz...Dr Reddy's Launches Generic Version Of Mercks Proscar Tablets
Pharma major Dr Reddy's Laboratories today announced that it has launched the authorized generic version of Merck's Proscar tablets 5 mg (Finasteride) on June 19. // The company has also launched the authorized generic version of Merck's Zocor tablets (Simvastatin) 5 mg, 10 mg, 20 mg, 40 mg and 80 mg yesterday, a company release said. In January this year, the company ente...Aurobindo Gets USFDA Approval for Didanosine Chewable Tablets
Aurobindo Pharma Ltd today said it has received tentative approval by USFDA for its anti-HIV drug, Didanosine chewable tablets of 100mg, 150mg and 200mg strengths. // This is the first generic version approval for Didanosine chewable in the world given by USFDA, Aurobindo Pharma informed the Bombay Stock Exchange. The aforesaid product would now be available for purchase un...Ranbaxy Launches Clarithromycin, Terbinafine Tablets in Japan
Ranbaxy Laboratories Ltd today said Nihon Pharmaceutical Industry Ltd, a joint venture between the company and Japan-based Nippon Chemiphar Ltd // , has launched the antibiotic 'Clarithromycin' and anti-fungal 'Terbinafine' tablets in the Japanese market. Clarithromycin has been launched in strengths of 50mg, 200mg and Terbinafine of 125mg. The products have a market size of around 4...Insulin Tablets-No More Injections
It may be still far from reality, but the very idea is bound to gladden diabetics. Scientists have announced the possibility of administering insulin orally//, instead of the common injections.At, present insulin is given via injections or via inhalation like Exubera, a recent invention. Scientists from Taiwan’s National Tsing Hua University have published results of their study in t...Vitamin D Tablets to Cure Prostate Cancer
Novacea , a drug company has designed a vitamin D tablet Asentar, to treat advanced prostate cancer. Vitamin D from sunlight is known to slow down certain cancers. But consuming natural levels// of the vitamin has no significant effect. The drug, Asentar (DN-101) provides levels of vitamin D 50-100 times higher than normal and can be given to patients in the advanced stages of prostat...Ranbaxy Launches Pravastatin Sodium Tablets in US
Mumbai, June 25 (IANS) Indian pharmaceutical major Ranbaxy Laboratories Ltd Monday said it had launched in the US pravastatin sodium tablets, meant for heart diseases . Being the first-to-file, the company will enjoy a 180-day exclusivity for the pravastatin 80mg and benefit from the commercial gains during the period, it informed the Bombay Stock Exchange (BSE). The a...Timberlake's Tour Demands Include 'anti-gas Tablets'!
Singer Justin Timberlake has reportedly outdone many of his other colleagues in the industry with his huge list of tour demands, which includes Beano anti-gas tablets from America for his tour of Europe. A source said that the singer has given a huge list of demands, and that the tablets are quite difficult to get in Europe. "Justin had a long list of demands includin...